Learn how to achieve optimal control of psoriatic arthritis, recognize signs of inadequate treatment, and advocate for better ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

UCB (UCBJY) announced on Tuesday that its biologic medicine Bimzelx outperformed AbbVie’s (ABBV) immunology therapy Skyrizi ...

Despite incremental gains in awareness and prescribing, most launch metrics continue to trail recent rheumatology benchmarks, ...

Psoriatic arthritis (PsA) is often misunderstood, and those misconceptions can make it harder for people to recognize ...

Two months after UCB revealed the success of Bimzelx in a head-to-head trial against AbbVie’s Skyrizi in patients with psoriatic arthritis (PsA), the Belgian drugmaker has unveiled the detailed ...

Psoriatic arthritis (PsA) has been around for thousands of years. Archaeologists unearthed Egyptian mummies with signs of the disease. Back then, the treatments for swollen and painful joints and red, ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Psoriatic arthritis happens when your immune system mistakenly attacks healthy cells in your body. (About 1.5 million 2 people in America have psoriatic arthritis.) If you are trying to determine ...

Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis—a condition that features red patches of skin topped with silvery scales. Most people develop psoriasis first and ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

Psoriatic arthritis is a kind of autoimmune inflammatory arthritis, which develops in 30 percent of people with the skin condition of psoriasis. Psoriasis is a skin condition that causes a red rash, ...